Targeting Medication Non-Adherence Behavior in Selected Autoimmune Diseases: A Systematic Approach to Digital Health Program Development

Abstract

Background29 autoimmune diseases, including Rheumatoid Arthritis, gout, Crohn’s Disease, and Systematic Lupus Erythematosus affect 7.6-9.4% of the population. While effective therapy is available, many patients do not follow treatment or use medications as directed. Digital health and Web 2.0 interventions have demonstrated much promise in increasing medication and treatment adherence, but to date many Internet tools have proven disappointing. In fact, most digital interventions continue to suffer from high attrition in patient populations, are burdensome for healthcare professionals, and have relatively short life spans.ObjectiveDigital health tools have traditionally centered on the transformation of existing interventions (such as diaries, trackers, stage-based or cognitive behavioral therapy programs, coupons, or symptom checklists) to electronic format. Advanced digital interventions have also incorporated attributes of Web 2.0 such as social networking, text messaging, and the use of video. Despite these efforts, there has not been little measurable impact in non-adherence for illnesses that require medical interventions, and research must look to other strategies or development methodologies. As a first step in investigating the feasibility of developing such a tool, the objective of the current study is to systematically rate factors of non-adherence that have been reported in past research studies.MethodsGrounded Theory, recognized as a rigorous method that facilitates the emergence of new themes through systematic analysis, data collection and coding, was used to analyze quantitative, qualitative and mixed method studies addressing the following autoimmune diseases: Rheumatoid Arthritis, gout, Crohn’s Disease, Systematic Lupus Erythematosus, and inflammatory bowel disease. Studies were only included if they contained primary data addressing the relationship with non-adherence.ResultsOut of the 27 studies, four non-modifiable and 11 modifiable risk factors were discovered. Over one third of articles identified the following risk factors as common contributors to medication non-adherence (percent of studies reporting): patients not understanding treatment (44%), side effects (41%), age (37%), dose regimen (33%), and perceived medication ineffectiveness (33%). An unanticipated finding that emerged was the need for risk stratification tools (81%) with patient-centric approaches (67%).ConclusionsThis study systematically identifies and categorizes medication non-adherence risk factors in select autoimmune diseases. Findings indicate that patients understanding of their disease and the role of medication are paramount. An unexpected finding was that the majority of research articles called for the creation of tailored, patient-centric interventions that dispel personal misconceptions about disease, pharmacotherapy, and how the body responds to treatment. To our knowledge, these interventions do not yet exist in digital format. Rather than adopting a systems level approach, digital health programs should focus...

Impact of Treatment-Related Beliefs on Medication Adherence in Immune-Mediated Inflammatory Diseases: Results of the Global ALIGN Study

“…In addition, in at least four of the six IMIDs, older age and Caucasian race were associated with better medication adherence. Age or race/ethnicity as factors affecting medication adherence were noted in patients with RA or other immune diseases in previous studies [18, 39–44]. In our study, Caucasians in general harbored significantly less concerns and overuse beliefs but not higher treatment necessity beliefs compared with non-Caucasians.…”

The relationship between social support and health-related quality of life in patients with antiphospholipid (hughes) syndrome

“…By extension, this might be suggestive of the beneficial effect of social support on HRQoL in patients with APS either through medication adherence or also through more effective coping skills. Lack of support in terms of providing diseaseand medication-specific information has been associated with decreased medication adherence in patients with autoimmune diseases [48]. In addition, increased informational support especially by knowledgeable health professionals might improve provision of support by patients' family and friends through reducing "invalidation" [29].…”

A Retrospective Longitudinal Database Study of Persistence and Compliance with Treatment of Osteoporosis in Hungary

“…It is possible that compliance may have been overestimated in the current study. Also, because the retrospective calculation of MPR is based on the assumption that patients take all medications for which they have prescriptions filled, and does not take into account whether drugs are taken in accordance with the prescribing instructions, it is possible that compliance may have been overestimated [42]. Nonetheless, MPR is commonly used in this type of study [8,12,28,37,38], and its use for measuring compliance is recommended by the International Society for Pharmacoeconomics and Outcomes Research [43].…”